Porokeratosis on the Foot (PPD): A Nucleated Callus, Not a Wart

Quick answer

Porokeratosis plantaris discreta (PPD) is a small, deep, often very painful keratotic lesion on the sole of the foot. It looks like ordinary hard skin, so it’s frequently dismissed as a callus or mistaken for a plantar wart, but it’s really a nucleated callus: surface callus with a discrete keratin core underneath, surrounded by a thin translucent ring, that hurts disproportionately for its size. Filing the surface never reaches the core, which is why home treatment fails. When the lesion is debrided down to the core in clinic, relief is typically immediate.

Important, get evaluated first. A persistent, painful lesion on the sole can be PPD, an intractable plantar keratosis, a plantar wart, an eccrine poroma, or rarely something more concerning. The treatments diverge meaningfully, particularly if you have diabetes, peripheral neuropathy, or peripheral arterial disease, where a sole lesion can sit on top of an early ulcer. Don’t pare or use over-the-counter acid removers on a sole lesion you can’t confidently identify; see a podiatrist or dermatologist.

How to recognize it

PPD lesions tend to share a distinctive set of features:

• Small: usually 1–10 mm in diameter
• Discrete: sharp borders, with a clear edge between the lesion and surrounding skin (unlike a diffuse callus, which fades into normal skin)
• A central core: a deep keratin plug, sometimes appearing translucent or yellow-white
• A surrounding “halo” ring of slightly thickened skin
• Disproportionately painful for its size, often the most striking feature on history
• Often on weight-bearing areas: most commonly under the 2nd, 3rd, or 4th metatarsal head, but unlike a typical callus, PPD can also appear in non-weight-bearing areas of the sole, which is a clue that it isn’t purely a pressure callus
• Skin lines preserved through the lesion (unlike a plantar wart, which disrupts the skin lines)

Many people first notice PPD as a sharp, focal pain when walking or after a long day on their feet; they expect to find a wart or splinter and instead find a small, dense, callus-like spot.

How it differs from a callus and a plantar wart

This is the diagnosis most often gotten wrong, and the distinction matters because each is treated differently.

In practice, a quick sharp paring with a #15 blade in clinic settles the diagnosis fast: a callus simply reveals more callus, a wart reveals pinpoint bleeding as the disrupted capillaries are exposed, and a PPD reveals its discrete central plug. The bleeding is the most useful single sign of a wart in the day-to-day exam.

A note on terminology. “Porokeratosis plantaris discreta” was named by Steinberg in the 1950s based on a presumed origin from blocked eccrine sweat ducts: the poro- in the name refers to the duct opening. A 1990 study by Limmer, Sansone, and Beach examined biopsy specimens and argued that the histology doesn’t consistently match the classic description, calling the term a “misnomer.” Some clinicians prefer to call these lesions discrete intractable plantar keratoses instead. The label you’ll see in your chart depends on your clinician, but the lesion they’re describing is the same.

Why it happens

Several theories exist; none is fully proven. The most commonly cited:

• Eccrine sweat duct theory (Steinberg, 1950s): a duct gets occluded, the keratin plug forms in response, and the lesion grows around it. This is where the poro- name comes from.
• Localized keratinization disorder: a focal abnormality in how the skin makes and sheds keratin, possibly cued by chronic mechanical pressure
• Mechanical pressure alone: favored by those who consider PPD a variant of intractable plantar keratosis (IPK) rather than a separate entity

In practice, most cases occur in adults who put significant pressure on their soles: runners, dancers, people with high arches, hammertoes, bunions, or other foot mechanics that concentrate load on a small area. But genetics, friction, and sweat-duct biology likely all play a role.

How a clinician makes the diagnosis

Diagnosis is clinical: based on the appearance, location, and what’s revealed when the surface keratin is gently pared down in clinic:

• Sharp paring with a #15 blade is the single most useful step. A callus reveals more callus; a wart reveals pinpoint bleeding as the abnormal capillaries are unroofed; a PPD reveals a discrete, well-circumscribed keratin core that debrides out.
• Skin-line inspection with a magnifier or dermoscope, preserved lines suggest callus or PPD; disrupted lines suggest wart
• Location: weight-bearing areas alone strongly favor callus / IPK; non-weight-bearing areas raise PPD or wart
• Biopsy is rarely needed but is the definitive answer when the diagnosis is unclear or the lesion fails standard treatment

Treatment

The single most useful intervention for PPD is sharp debridement in clinic: and in current podiatric practice, that’s almost always all that’s needed. Most lesions resolve with periodic debridement plus addressing the pressure that’s driving them. The procedural treatments described in older textbooks (cryotherapy, 5-FU, sclerosing injections) are used much less often today because debridement-led management works for the great majority of patients.

First-line: and usually the only line, care

• Sharp debridement: a podiatrist pares the overlying keratin with a #15 blade and debrides out the central keratin core. Pain relief is typically immediate, and many lesions resolve entirely after one or a few debridement visits. For lesions that recur, periodic debridement every 4–12 weeks keeps patients comfortable indefinitely.
• Offloading: pads (felt, silicone, or foam) cut to surround the lesion and redirect pressure away from it; custom orthotics with a cutout under the affected spot; rocker-bottom shoes for forefoot lesions
• Topical keratolytics: salicylic acid (17–40%) or urea creams (20–40%) at home between visits to soften the surrounding callus and slow plug regrowth. Skip these entirely if you have diabetes, peripheral neuropathy, or poor circulation: the active ingredient can damage healthy skin you can’t feel.
• Activity and footwear modification: wider toe boxes, well-cushioned soles, replacing worn shoes; reducing high-impact loading during flares

If a lesion is recurring repeatedly in the same spot, the more durable fix is usually addressing the mechanical driver: a hammertoe, a dropped metatarsal head, a tailor’s bunion, or another bony prominence pressing on that area, rather than escalating skin treatment.

Less commonly used today

The following are documented historically and still occasionally used for genuinely refractory cases, but most podiatrists today don’t reach for them as routine treatment for PPD:

• Cryotherapy (cryosurgery): liquid nitrogen freezing of the lesion. A 1979 study by Limmer reported a 90.5% cure rate, but the technique fell out of favor as debridement-led management proved sufficient for most patients and cryotherapy can be painful for days afterward.
• Topical 5-fluorouracil (5-FU): chemotherapy cream with documented efficacy in some porokeratosis variants. Used much more often in dermatology for actinic keratoses than in podiatry for PPD today.
• Intralesional sclerosing injections: historical podiatric technique using dilute alcohol or other sclerosants, given weekly. Rarely used in current practice.
• Ablative laser (CO₂, erbium:YAG), curettage and electrodesiccation, photodynamic therapy, topical vitamin D analogs, topical retinoids: all described in the broader porokeratosis literature; rarely first- or second-line for PPD specifically.

Surgical excision

For the rare PPD that doesn’t respond to debridement and offloading despite a real trial, surgical excision is an option of last resort. The trade-off on a weight-bearing sole is significant: the resulting scar can become a new pressure point, sometimes more painful than the original PPD. Surgeons reserve excision for clearly demarcated, isolated lesions in non-critical pressure areas, and counsel patients about recurrence and scar-related discomfort.

When a bony prominence is driving the problem, a metatarsal osteotomy or other structural correction may be more durable than treating the surface lesion alone, same principle as the structural-correction options discussed for chronic calluses and corns.

The realistic plan for almost all PPD: in-clinic debridement, address the pressure pattern (offloading, padding, orthotics, footwear), repeat debridement on a maintenance schedule if the lesion recurs. The procedural and surgical options exist for the small number of cases that don’t respond, and for those, the decision is best made with a podiatrist who has examined your foot and reviewed the mechanical drivers.

When to see a clinician

Make an appointment if you have:

• A painful, deep, persistent lesion on the sole that hasn’t resolved with shoe changes, padding, or gentle filing over 4–6 weeks
• A lesion you can’t confidently identify as a callus, wart, or something else
• A lesion that’s growing, changing color, bleeding, or developing a darker spot
• Recurring sole pain in the same spot despite repeated home treatment
• Diabetes, peripheral neuropathy, or peripheral arterial disease: any new or persistent sole lesion in this group warrants prompt evaluation, since what looks like a callus or PPD can sit on top of a developing ulcer

Bottom line

PPD is a small but disproportionately painful sole lesion that’s commonly mistaken for a callus or plantar wart. The distinguishing features, discrete borders, a central core with a translucent halo, preserved skin lines, and the ability to occur in non-weight-bearing areas, are best appreciated in person by a clinician who looks at sole lesions every day. The first step is the right diagnosis; the second is in-clinic debridement. Most PPDs resolve, or stay comfortably controlled, with periodic debridement and offloading of the area that’s getting the pressure. The older procedural options (cryotherapy, 5-FU, sclerosing injections, excision) exist for genuinely refractory cases but are rarely needed. This page is general educational information; the diagnosis and treatment plan need to come from a clinician who has examined your foot.